BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38415994)

  • 1. Chronic oral diseases secondary to COVID-19 infection or vaccination: clinical cases and a narrative review.
    Fitzpatrick S; Cha S; Katz J; Migliorati C
    Quintessence Int; 2024 May; 55(5):400-411. PubMed ID: 38415994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune skin disorders and SARS-CoV-2 vaccination - a meta-analysis.
    Hinterseher J; Hertl M; Didona D
    J Dtsch Dermatol Ges; 2023 Aug; 21(8):853-861. PubMed ID: 37218538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune mucocutaneous blistering diseases after SARS-Cov-2 vaccination: A Case report of Pemphigus Vulgaris and a literature review.
    Calabria E; Canfora F; Mascolo M; Varricchio S; Mignogna MD; Adamo D
    Pathol Res Pract; 2022 Apr; 232():153834. PubMed ID: 35278817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral lesions after COVID-19 vaccination: Immune mechanisms and clinical approach.
    Khazeei Tabari MA; Najary S; Khadivi G; Yousefi MJ; Samieefar N; Abdollahimajd F
    Infect Med (Beijing); 2022 Sep; 1(3):171-179. PubMed ID: 38014364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunological aspects of various oral diseases. III. Aphthous stomatitis, pemphigus, benign mucomembranous pemphigoid, DLE, lichen planus, desquamative gingivitis, inflammatory intestinal disease with oral manifestations, Sjögren syndrome].
    Gombos F; Serpico R; Astarita GP
    Arch Stomatol (Napoli); 1985; 26(2):215-30. PubMed ID: 3870081
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral lesions in patients with pemphigus vulgaris and bullous pemphigoid.
    Budimir J; Mihić LL; Situm M; Bulat V; Persić S; Tomljanović-Veselski M
    Acta Clin Croat; 2008 Mar; 47(1):13-8. PubMed ID: 18714642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral mucosal diseases in the office setting--Part II: oral lichen planus, pemphigus vulgaris, and mucosal pemphigoid.
    Sciubba JJ
    Gen Dent; 2007; 55(5):464-76; quiz 477-8, 488. PubMed ID: 17899727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of an Oral Disease Severity Score (ODSS) tool for use in oral mucous membrane pemphigoid.
    Ormond M; McParland H; Thakrar P; Donaldson ANA; Andiappan M; Cook RJ; Escudier ME; Higham J; Hullah E; McMillan R; Taylor J; Shirlaw PJ; Challacombe SJ; Setterfield JF
    Br J Dermatol; 2020 Jul; 183(1):78-85. PubMed ID: 31571192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopathogenic Oral Diseases: An Overview 
Focusing on Pemphigus Vulgaris and Mucous Membrane Pemphigoid.
    Feller L; Ballyram R; Khammissa RA; Altini M; Lemmer J
    Oral Health Prev Dent; 2017; 15(2):177-182. PubMed ID: 28322362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermatopathology of COVID-19 infection and vaccination.
    Fernández-Figueras MT
    Pathologie (Heidelb); 2022 Aug; 43(Suppl 1):114-118. PubMed ID: 36197514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual diagnosis of Pemphigus and pemphigoid. Retrospective review of thirty cases in the literature.
    Sami N; Ahmed AR
    Dermatology; 2001; 202(4):293-301. PubMed ID: 11455140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pemphigus vulgaris after SARS-CoV-2 vaccination: A case with new-onset and two cases with severe aggravation.
    Akoglu G
    Dermatol Ther; 2022 May; 35(5):e15396. PubMed ID: 35187768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune bullous disorder flares following severe acute respiratory syndrome coronavirus 2 vaccination: a case series.
    Rasner CJ; Schultz B; Bohjanen K; Pearson DR
    J Med Case Rep; 2023 Sep; 17(1):408. PubMed ID: 37749657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic delay in autoimmune oral diseases.
    Petruzzi M; Della Vella F; Squicciarini N; Lilli D; Campus G; Piazzolla G; Lucchese A; van der Waal I
    Oral Dis; 2023 Oct; 29(7):2614-2623. PubMed ID: 36565434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral mucous membrane pemphigoid after SARS-CoV-2 vaccination.
    Calabria E; Antonelli A; Lavecchia A; Giudice A
    Oral Dis; 2024 Mar; 30(2):782-783. PubMed ID: 36516333
    [No Abstract]   [Full Text] [Related]  

  • 16. A comprehensive review of oral microenvironment changes and orofacial adverse reactions after COVID-19 vaccination: The good, the bad, and the ugly.
    Najary S; Vatankhah M; Khadivi G; Salehi SN; Tabari MAK; Samieefar N; Behnaz M
    Health Sci Rep; 2024 Mar; 7(3):e1967. PubMed ID: 38482134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acquired bullous diseases of the oral mucosa].
    Vaillant L; Hüttenberger B
    Rev Stomatol Chir Maxillofac; 2005 Nov; 106(5):287-97. PubMed ID: 16292223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin-infiltrating T cells display distinct inflammatory signatures in lichen planus, bullous pemphigoid and pemphigus vulgaris.
    Schinner J; Cunha T; Mayer JU; Hörster S; Kind P; Didona D; Keber C; Hertl M; Worzfeld T; Juratli HA
    Front Immunol; 2023; 14():1203776. PubMed ID: 37415985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reflectance confocal microscopy as a new tool in the in vivo evaluation of desquamative gingivitis: patterns in mucous membrane pemphigoid, pemphigus vulgaris and oral lichen planus.
    Alessi SS; Nico MM; Fernandes JD; Lourenço SV
    Br J Dermatol; 2013 Feb; 168(2):257-64. PubMed ID: 22924499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe acute respiratory syndrome coronavirus 2 infection in patients with autoimmune bullous diseases in China.
    Zhang JL; Wang SH; Cui SN; Zhang J; Li SZ; Li L; Zuo YG
    J Dermatol; 2023 Nov; 50(11):1433-1441. PubMed ID: 37501390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.